Rhythm Pharmaceuticals (RYTM) Non-cash Items (2017 - 2024)

Rhythm Pharmaceuticals (RYTM) has 8 years of Non-cash Items data on file, last reported at $4.6 million in Q4 2024.

• Non-cash Items for Q4 2024 came in at $4.6 million, up 16.33% year-over-year; the trailing twelve-month figure through Dec 2024 was $4.6 million (up 16.33% YoY), and the FY2024 annual result was $4.6 million, up 16.33% from the prior year.
• Non-cash Items climbed to $4.6 million in Q4 2024 per RYTM's latest filing, from $3.9 million in the prior quarter.
• Over five years, Non-cash Items peaked at $74.0 million in Q4 2022 and troughed at $3.2 million in Q4 2021.
• A 5-year average of $26.2 million and a median of $4.6 million in 2024 frame the typical range for Non-cash Items.
• The sharpest annual moves came in 2022 and 2023: Non-cash Items jumped 2202.24% in 2022, then sank 94.68% in 2023.
• A 5-year view of Non-cash Items shows it stood at $45.2 million in 2020, then plunged by 92.89% to $3.2 million in 2021, then jumped by 2202.24% to $74.0 million in 2022, then slumped by 94.68% to $3.9 million in 2023, then gained by 16.33% to $4.6 million in 2024.
• Business Quant data shows RYTM's Non-cash Items at $4.6 million in Q4 2024, $3.9 million in Q4 2023, and $74.0 million in Q4 2022.